Coronavirus disease (COVID-19) comes from a strain of coronavirus, or SARS-CoV-2, first detected in December 2019.
In response to the evolving health emergency, HTA Philippines has been conducting rapid reviews to support policy- and decision-makers. Recognizing calls to strengthen national crisis response efforts, we conduct our assessments at the request of the Secretary of Health. This helps ensure urgent access to the best available evidence to guide decisions at every stage of the pandemic.
COVID – 19 HEALTH TECHNOLOGY REVIEWS
COVID -19 Devices
COVID -19 Investigational Drugs